While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

As health complications and deaths from alcohol use disorder (AUD) increase in the United States, it is critical that people ...

But the newest study that has gone viral is an even more impressive outcome. Headlines are claiming that researchers have ...

A phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving with low-dose semaglutide. HealthDay News — Low-dose semaglutide seems to reduce craving and certain ...

The company unveiled plans last week to test its GLP-1/glucagon dual receptor agonist in alcohol use disorder and ...

Lawmakers are hoping to expand and improve upon a 2015 law that offers grants to county jails treating inmates experiencing ...

Semaglutide shows promise in reducing alcohol cravings and consumption. Could it be a future treatment for AUD?

As a cancer survivor, I overcame alcohol addiction and urge others to seek support, safe detox and sobriety to improve their ...

GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.

Discover the 5 ways alcohol progressively harms your liver, from early warning signs to serious complications, plus expert ...

Without treatment, gastritis can cause peptic ... If you already have a stomach ulcer, it’s best to reduce your alcohol consumption or stop drinking alcohol altogether. Alcohol can prevent ...

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...